Grading the severity of obstruction in mixed obstructive-restrictive lung disease

Chest

Volumn 140, Issue 3, 2011, Pages 598-603

  Gardner, Zechariah S ^a   Ruppel, Gregg L ^b   Kaminsky, David A ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AMERICAN THORACIC SOCIETY EUROPEAN RESPIRATORY SOCIETY GRADING; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL CLASSIFICATION; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DISEASE; LUNG FLOW VOLUME CURVE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIXED OBSTRUCTIVE RESTRICTIVE LUNG DISEASE; PRIORITY JOURNAL; TOTAL LUNG CAPACITY;

EID: 80052669894     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2860     Document Type: Article

References (24)

1. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968. (Pubitemid 41632054)
2. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2(1):8-11. (Pubitemid 40562956)
3. Balfe DL, Lewis M, Mohsenifar Z. Grading the severity of obstruction in the presence of a restrictive ventilatory defect. Chest. 2002;122(4):1365-1369. (Pubitemid 35339554)
4. National Heart, Lung, and Blood Institute; World Health Organization. Global Initiative for Chronic Obstructive Lung Disease, 2009. Global Initiative for Chronic Obstructive Lung Disease Web site. http://www.goldcopd.com. Accessed November 4, 2010.
5. National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma, 2007. National Heart, Lung, and Blood Institute Web site. http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed November 4, 2010.
6. Morris A, Kanner R, Crapo R, Gardner R. Clinical Pulmonary Function Testing. A Manual of Uniform Laboratory Proce dures.Salt Lake City, UT: Intermountain Thoracic Society; 1984.
7. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5):1202-1218.
8. Agusti C, Xaubet A, Agusti A, Roca J, Ramirez J, Rodriguez-Roisin R. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. Eur Respir J. 1994;7(4):643-650. (Pubitemid 24122957)
9. Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med. 2009;103(8):1209-1215.
10. Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest. 1997;111(1):51-57. (Pubitemid 27043606)
11. Johnston ID, Prescott RJ, Chalmers JC, Rudd RM; Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax. 1997;52(1):38-44. (Pubitemid 27047223)
12. Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest. 2007;131(3):657-663. (Pubitemid 46446854)
13. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003;167(7):962-969. (Pubitemid 36408161)
14. Miller MR, Hankinson J, Brusasco V, et al ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. (Pubitemid 41079078)
15. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511-522. (Pubitemid 41264217)
16. Goldman HI, Becklake MR. Respiratory function tests; normal values at median altitudes and the prediction of normal results. Am Rev Tuberc. 1959;79(4):457-467.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-187. (Pubitemid 29036522)
18. Kleinbaum D, Kupper L, Muller K. Applied Regression Analysis and Other Multivariable Methods. 2nd ed. Boston, MA: PWS-KENT Publishing; 1988.
19. Bowker AH. A test for symmetry in contingency tables. J Am Stat Assoc. 1948;43(244):572-574.
20. Diaz-Guzman E, McCarthy K, Siu A, Stoller JK. Frequency and causes of combined obstruction and restriction identified in pulmonary function tests in adults. Respir Care. 2010;55(3):310-316.
21. Dykstra BJ, Scanlon PD, Kester MM, Beck KC, Enright PL. Lung volumes in 4,774 patients with obstructive lung disease. Chest. 1999;115(1):68-74. (Pubitemid 29047055)
22. Hong Y, Ra SW, Shim TS, et al. Poor interpretation of pulmonary function tests in patients with concomitant decreases in FEV1 and FVC. Respirology. 2008;13(4):569-574. (Pubitemid 351725274)
23. Fisher LR, Cawley MI, Holgate ST. Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis. 1990;49(11):921-925. (Pubitemid 20360758)
24. De Troyer A, Borenstein S, Cordier R. Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax. 1980;35(8):603-610. (Pubitemid 10055766)